Henry Schein Past Earnings Performance
Past criteria checks 1/6
Henry Schein's earnings have been declining at an average annual rate of -3%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 6.9% per year. Henry Schein's return on equity is 8.1%, and it has net margins of 3.1%.
Key information
-3.0%
Earnings growth rate
-0.3%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 6.9% |
| Return on equity | 8.1% |
| Net Margin | 3.1% |
| Last Earnings Update | 30 Mar 2024 |
Recent past performance updates
Recent updates
Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?
May 02
There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital
Apr 14Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward
Feb 28Is Henry Schein (NASDAQ:HSIC) A Risky Investment?
Oct 11Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?
Sep 23Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?
Aug 21Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively
Aug 01These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well
Jul 09At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?
Jun 09Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?
May 21Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns
May 01Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly
Apr 10Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)
Feb 15Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled
Jan 28These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well
Jan 10Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?
Dec 11Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?
Nov 04Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios
Aug 25Henry Schein announces $400M increase to stock buyback plan
Aug 18If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity
Aug 09Henry Schein Q2 2022 Earnings Preview
Aug 01Be Wary Of Henry Schein (NASDAQ:HSIC) And Its Returns On Capital
Jul 04Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet?
Jun 14Henry Schein: Neutral On Valuation, Covid-19 Sales Slowdown
Jun 09Henry Schein, Inc. (NASDAQ:HSIC) Shares Could Be 45% Below Their Intrinsic Value Estimate
May 27Does Henry Schein (NASDAQ:HSIC) Deserve A Spot On Your Watchlist?
May 10Investors Could Be Concerned With Henry Schein's (NASDAQ:HSIC) Returns On Capital
Apr 04Henry Schein: A Great Play On Medical And Dental Products Trading At An Attractive Price
Mar 07Revenue & Expenses BreakdownBeta
How Henry Schein makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Mar 24 | 12,451 | 388 | 3,030 | 0 |
| 30 Dec 23 | 12,339 | 416 | 2,956 | 0 |
| 30 Sep 23 | 12,693 | 445 | 2,898 | 0 |
| 01 Jul 23 | 12,598 | 458 | 2,833 | 0 |
| 01 Apr 23 | 12,528 | 478 | 2,806 | 0 |
| 31 Dec 22 | 12,647 | 538 | 2,771 | 0 |
| 24 Sep 22 | 12,607 | 638 | 2,732 | 0 |
| 25 Jun 22 | 12,718 | 650 | 2,747 | 0 |
| 26 Mar 22 | 12,655 | 646 | 2,702 | 0 |
| 25 Dec 21 | 12,401 | 631 | 2,634 | 0 |
| 25 Sep 21 | 12,236 | 626 | 2,581 | 0 |
| 26 Jun 21 | 11,898 | 606 | 2,484 | 0 |
| 27 Mar 21 | 10,615 | 438 | 2,294 | 0 |
| 26 Dec 20 | 10,119 | 403 | 2,086 | 0 |
| 26 Sep 20 | 9,622 | 591 | 2,188 | 0 |
| 27 Jun 20 | 9,291 | 585 | 2,203 | 0 |
| 28 Mar 20 | 10,054 | 713 | 2,351 | 0 |
| 28 Dec 19 | 9,986 | 701 | 2,358 | 0 |
| 28 Sep 19 | 9,789 | 488 | 2,301 | 0 |
| 29 Jun 19 | 9,636 | 444 | 2,278 | 0 |
| 30 Mar 19 | 9,504 | 438 | 2,238 | 0 |
| 29 Dec 18 | 9,418 | 431 | 2,217 | 0 |
| 29 Sep 18 | 10,263 | 304 | 2,319 | 0 |
| 30 Jun 18 | 11,069 | 352 | 2,384 | 0 |
| 31 Mar 18 | 11,812 | 377 | 2,460 | 0 |
| 30 Dec 17 | 8,883 | 293 | 2,072 | 0 |
| 30 Sep 17 | 12,264 | 554 | 2,504 | 0 |
| 01 Jul 17 | 11,968 | 550 | 2,468 | 0 |
| 01 Apr 17 | 11,782 | 534 | 2,440 | 0 |
| 31 Dec 16 | 11,572 | 507 | 2,409 | 0 |
| 24 Sep 16 | 11,302 | 498 | 2,366 | 0 |
| 25 Jun 16 | 11,122 | 492 | 2,336 | 0 |
| 26 Mar 16 | 10,879 | 489 | 2,296 | 0 |
| 26 Dec 15 | 10,630 | 479 | 2,238 | 0 |
| 26 Sep 15 | 10,481 | 482 | 2,219 | 0 |
| 27 Jun 15 | 10,419 | 469 | 2,215 | 0 |
| 28 Mar 15 | 10,405 | 467 | 2,202 | 0 |
| 27 Dec 14 | 10,371 | 466 | 2,196 | 0 |
| 27 Sep 14 | 10,196 | 457 | 2,147 | 0 |
| 28 Jun 14 | 9,921 | 450 | 2,079 | 0 |
| 29 Mar 14 | 9,697 | 442 | 2,025 | 0 |
| 28 Dec 13 | 9,561 | 432 | 1,979 | 0 |
| 28 Sep 13 | 9,443 | 420 | 1,948 | 0 |
| 29 Jun 13 | 9,325 | 409 | 1,929 | 0 |
Quality Earnings: HSIC has high quality earnings.
Growing Profit Margin: HSIC's current net profit margins (3.1%) are lower than last year (3.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HSIC's earnings have declined by 3% per year over the past 5 years.
Accelerating Growth: HSIC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: HSIC had negative earnings growth (-19.1%) over the past year, making it difficult to compare to the Healthcare industry average (12.5%).
Return on Equity
High ROE: HSIC's Return on Equity (8.1%) is considered low.